Commercial AI platforms improve reproducibility but fail to meet clinical precision thresholds for intracranial aneurysm measurement: implications for serial surveillance
Can Yin, Linan Hu, Shengwu Duan, Xiqing Deng
Springer Nature ·
2026-02-07
· DOI 10.1186/s12880-026-02209-2
The publisher did not provide an abstract — full text is available via the link below.
Can Yin, Linan Hu, Shengwu Duan, Xiqing Deng. Commercial AI platforms improve reproducibility but fail to meet clinical precision thresholds for intracranial aneurysm measurement: implications for serial surveillance. // BMC Medical Imaging. – 2026. – DOI: 10.1186/s12880-026-02209-2. – URL: https://doi.org/10.1186/s12880-026-02209-2
Can Yin, Linan Hu, Shengwu Duan, & Xiqing Deng (2026). Commercial AI platforms improve reproducibility but fail to meet clinical precision thresholds for intracranial aneurysm measurement: implications for serial surveillance. BMC Medical Imaging. https://doi.org/10.1186/s12880-026-02209-2
Can Yin, et al. “Commercial AI platforms improve reproducibility but fail to meet clinical precision thresholds for intracranial aneurysm measurement: implications for serial surveillance.” BMC Medical Imaging, 2026. doi:10.1186/s12880-026-02209-2.
@article{Yin2026,
title = {Commercial AI platforms improve reproducibility but fail to meet clinical precision thresholds for intracranial aneurysm measurement: implications for serial surveillance},
author = {Yin, Can and Hu, Linan and Duan, Shengwu and Deng, Xiqing},
journal = {BMC Medical Imaging},
year = {2026},
doi = {10.1186/s12880-026-02209-2},
url = {https://doi.org/10.1186/s12880-026-02209-2}
}